| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 34 | 2021 | 428 | 4.630 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 12 | 2021 | 66 | 2.420 |
Why?
|
| Life Style | 15 | 2020 | 226 | 2.160 |
Why?
|
| Exercise | 21 | 2023 | 505 | 2.100 |
Why?
|
| Health Promotion | 11 | 2021 | 164 | 1.640 |
Why?
|
| Cholesterol | 6 | 2021 | 55 | 1.330 |
Why?
|
| Hypercholesterolemia | 7 | 2021 | 30 | 1.140 |
Why?
|
| Coronary Disease | 6 | 2010 | 86 | 1.020 |
Why?
|
| Anticholesteremic Agents | 8 | 2021 | 20 | 1.010 |
Why?
|
| Risk Factors | 20 | 2020 | 2591 | 0.960 |
Why?
|
| Primary Prevention | 6 | 2021 | 41 | 0.940 |
Why?
|
| Cardiology | 7 | 2018 | 75 | 0.850 |
Why?
|
| Health Behavior | 6 | 2021 | 163 | 0.810 |
Why?
|
| Risk Reduction Behavior | 8 | 2018 | 56 | 0.800 |
Why?
|
| Humans | 76 | 2023 | 31073 | 0.770 |
Why?
|
| Risk Assessment | 14 | 2021 | 718 | 0.700 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 71 | 0.700 |
Why?
|
| Hyperlipidemias | 5 | 2018 | 22 | 0.670 |
Why?
|
| Hypertension | 9 | 2016 | 288 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 9 | 2019 | 344 | 0.630 |
Why?
|
| United States | 20 | 2023 | 2376 | 0.630 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2018 | 10 | 0.610 |
Why?
|
| Dyslipidemias | 5 | 2021 | 23 | 0.590 |
Why?
|
| Societies, Medical | 1 | 2019 | 191 | 0.590 |
Why?
|
| Biomarkers | 9 | 2021 | 734 | 0.580 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 178 | 0.560 |
Why?
|
| Patient Selection | 4 | 2018 | 246 | 0.540 |
Why?
|
| Medication Adherence | 2 | 2015 | 73 | 0.520 |
Why?
|
| Patient Compliance | 4 | 2016 | 158 | 0.510 |
Why?
|
| Benchmarking | 4 | 2011 | 46 | 0.500 |
Why?
|
| Middle Aged | 31 | 2021 | 10240 | 0.490 |
Why?
|
| Global Health | 3 | 2011 | 58 | 0.490 |
Why?
|
| Patient Participation | 1 | 2015 | 53 | 0.490 |
Why?
|
| Social Environment | 1 | 2015 | 87 | 0.490 |
Why?
|
| Aged | 28 | 2020 | 10082 | 0.480 |
Why?
|
| Adult | 29 | 2019 | 8950 | 0.470 |
Why?
|
| Cholesterol, LDL | 6 | 2021 | 33 | 0.470 |
Why?
|
| Female | 36 | 2023 | 17017 | 0.470 |
Why?
|
| Diet, Fat-Restricted | 2 | 2012 | 7 | 0.470 |
Why?
|
| Evidence-Based Medicine | 6 | 2018 | 216 | 0.460 |
Why?
|
| Coronary Artery Disease | 4 | 2021 | 139 | 0.430 |
Why?
|
| Motor Activity | 7 | 2014 | 370 | 0.410 |
Why?
|
| Practice Patterns, Nurses' | 2 | 2016 | 18 | 0.410 |
Why?
|
| Secondary Prevention | 3 | 2021 | 67 | 0.390 |
Why?
|
| Health Education | 1 | 2011 | 41 | 0.370 |
Why?
|
| Ezetimibe | 3 | 2021 | 4 | 0.370 |
Why?
|
| Motivation | 3 | 2021 | 103 | 0.350 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2010 | 2 | 0.350 |
Why?
|
| Hypertriglyceridemia | 1 | 2010 | 21 | 0.350 |
Why?
|
| Nurses | 3 | 2021 | 49 | 0.350 |
Why?
|
| Workplace | 2 | 2021 | 20 | 0.340 |
Why?
|
| Health Status | 3 | 2021 | 239 | 0.340 |
Why?
|
| Medical Errors | 2 | 2021 | 29 | 0.340 |
Why?
|
| Healthy Lifestyle | 2 | 2021 | 38 | 0.330 |
Why?
|
| Nurse Clinicians | 1 | 2009 | 25 | 0.330 |
Why?
|
| Medical Order Entry Systems | 1 | 2008 | 3 | 0.320 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 93 | 0.320 |
Why?
|
| Primary Health Care | 2 | 2020 | 100 | 0.320 |
Why?
|
| Self Care | 1 | 2009 | 91 | 0.310 |
Why?
|
| Mental Health | 2 | 2021 | 113 | 0.300 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 155 | 0.300 |
Why?
|
| Referral and Consultation | 1 | 2008 | 91 | 0.300 |
Why?
|
| Patient Education as Topic | 4 | 2011 | 161 | 0.300 |
Why?
|
| Women's Health Services | 2 | 2018 | 12 | 0.300 |
Why?
|
| Education, Nursing, Graduate | 2 | 2023 | 95 | 0.300 |
Why?
|
| Heart Diseases | 1 | 2008 | 77 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 214 | 0.290 |
Why?
|
| Blood Pressure | 8 | 2015 | 262 | 0.290 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 109 | 0.280 |
Why?
|
| Male | 21 | 2020 | 16499 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 80 | 0.260 |
Why?
|
| Cardiac Rehabilitation | 1 | 2005 | 9 | 0.250 |
Why?
|
| Patient Care Team | 2 | 2019 | 152 | 0.250 |
Why?
|
| Obesity | 4 | 2016 | 307 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 1006 | 0.240 |
Why?
|
| Clinical Decision-Making | 3 | 2021 | 43 | 0.240 |
Why?
|
| American Heart Association | 5 | 2021 | 30 | 0.240 |
Why?
|
| Atherosclerosis | 2 | 2018 | 76 | 0.240 |
Why?
|
| Women's Health | 3 | 2018 | 242 | 0.230 |
Why?
|
| National Institute of Nursing Research (U.S.) | 1 | 2023 | 8 | 0.220 |
Why?
|
| Treatment Outcome | 10 | 2021 | 3810 | 0.210 |
Why?
|
| Self Efficacy | 2 | 2021 | 57 | 0.210 |
Why?
|
| Lipoprotein(a) | 2 | 2016 | 5 | 0.200 |
Why?
|
| Surveys and Questionnaires | 6 | 2021 | 1209 | 0.200 |
Why?
|
| Social Support | 2 | 2021 | 194 | 0.190 |
Why?
|
| Military Medicine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Chicago | 5 | 2016 | 941 | 0.190 |
Why?
|
| Palliative Care | 2 | 2020 | 154 | 0.190 |
Why?
|
| Cognitive Dysfunction | 2 | 2020 | 1095 | 0.180 |
Why?
|
| Qualitative Research | 2 | 2019 | 117 | 0.180 |
Why?
|
| Exercise Therapy | 2 | 2008 | 113 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 370 | 0.180 |
Why?
|
| Quality of Life | 3 | 2020 | 696 | 0.180 |
Why?
|
| Endothelium | 1 | 2020 | 14 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2020 | 38 | 0.170 |
Why?
|
| Residence Characteristics | 3 | 2016 | 225 | 0.170 |
Why?
|
| Preventive Medicine | 1 | 2019 | 12 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2020 | 52 | 0.170 |
Why?
|
| Insurance Coverage | 1 | 2019 | 16 | 0.170 |
Why?
|
| Counseling | 2 | 2010 | 49 | 0.170 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 4 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 42 | 0.170 |
Why?
|
| Nurse's Role | 2 | 2011 | 121 | 0.160 |
Why?
|
| Prognosis | 4 | 2018 | 924 | 0.160 |
Why?
|
| Physical Endurance | 3 | 1997 | 12 | 0.160 |
Why?
|
| Consensus | 4 | 2021 | 112 | 0.160 |
Why?
|
| Posture | 1 | 1999 | 72 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 52 | 0.160 |
Why?
|
| Adolescent | 5 | 2015 | 2403 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2012 | 30 | 0.150 |
Why?
|
| Marital Status | 1 | 2018 | 14 | 0.150 |
Why?
|
| Heart Failure | 2 | 2020 | 223 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 38 | 0.150 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 30 | 0.150 |
Why?
|
| Occupational Health | 1 | 2018 | 21 | 0.150 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 88 | 0.150 |
Why?
|
| Blogging | 1 | 2017 | 2 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2015 | 136 | 0.150 |
Why?
|
| Information Storage and Retrieval | 1 | 2017 | 5 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2017 | 17 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 135 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2018 | 165 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2018 | 144 | 0.140 |
Why?
|
| Self Concept | 1 | 1997 | 44 | 0.140 |
Why?
|
| Prevalence | 4 | 2016 | 499 | 0.140 |
Why?
|
| Age Factors | 3 | 2018 | 875 | 0.130 |
Why?
|
| Smoking | 2 | 2007 | 197 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2015 | 20 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2015 | 28 | 0.130 |
Why?
|
| Evidence-Based Nursing | 1 | 2016 | 27 | 0.130 |
Why?
|
| Cognition | 2 | 2020 | 1428 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 62 | 0.120 |
Why?
|
| Catecholamines | 1 | 1994 | 13 | 0.120 |
Why?
|
| Physical Fitness | 2 | 1994 | 60 | 0.120 |
Why?
|
| Cardiac Output | 1 | 1994 | 23 | 0.120 |
Why?
|
| Cardiomegaly | 1 | 1994 | 12 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 334 | 0.120 |
Why?
|
| Nutritional Sciences | 1 | 2014 | 8 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 1994 | 57 | 0.120 |
Why?
|
| Spouses | 1 | 2014 | 26 | 0.110 |
Why?
|
| Geriatric Nursing | 1 | 2013 | 21 | 0.110 |
Why?
|
| Pets | 1 | 2013 | 1 | 0.110 |
Why?
|
| Morbidity | 2 | 2011 | 65 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2013 | 48 | 0.110 |
Why?
|
| Liver Function Tests | 1 | 2012 | 26 | 0.110 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2012 | 13 | 0.110 |
Why?
|
| Creatine Kinase | 1 | 2012 | 34 | 0.110 |
Why?
|
| Health Personnel | 1 | 2014 | 118 | 0.110 |
Why?
|
| Child | 3 | 2015 | 1431 | 0.110 |
Why?
|
| Advanced Practice Nursing | 1 | 2013 | 48 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 39 | 0.100 |
Why?
|
| Exercise Test | 4 | 2005 | 129 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 110 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 555 | 0.100 |
Why?
|
| Specialties, Nursing | 1 | 2011 | 10 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 28 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1991 | 6 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 5197 | 0.090 |
Why?
|
| Homocysteine | 2 | 2007 | 8 | 0.090 |
Why?
|
| Protective Factors | 2 | 2021 | 20 | 0.090 |
Why?
|
| Sex Factors | 3 | 2018 | 510 | 0.090 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2020 | 22 | 0.090 |
Why?
|
| Oxygen Consumption | 4 | 1997 | 51 | 0.090 |
Why?
|
| Quality of Health Care | 4 | 2014 | 146 | 0.090 |
Why?
|
| Early Ambulation | 1 | 1989 | 20 | 0.080 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2009 | 3 | 0.080 |
Why?
|
| Nursing Methodology Research | 1 | 2009 | 26 | 0.080 |
Why?
|
| Societies, Nursing | 1 | 2009 | 21 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2020 | 244 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2010 | 101 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2011 | 691 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 223 | 0.080 |
Why?
|
| Time Factors | 3 | 2021 | 1680 | 0.080 |
Why?
|
| Medication Therapy Management | 2 | 2018 | 5 | 0.080 |
Why?
|
| Survival Rate | 1 | 2010 | 407 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 52 | 0.080 |
Why?
|
| Mass Screening | 2 | 2018 | 186 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2008 | 42 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 35 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 360 | 0.080 |
Why?
|
| Drug Monitoring | 2 | 2021 | 25 | 0.070 |
Why?
|
| Curriculum | 2 | 2023 | 173 | 0.070 |
Why?
|
| Inflammation | 1 | 2010 | 361 | 0.070 |
Why?
|
| Muscle Strength | 1 | 2008 | 136 | 0.070 |
Why?
|
| Clofibric Acid | 1 | 2006 | 3 | 0.070 |
Why?
|
| Alcoholism | 1 | 2007 | 85 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 68 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 128 | 0.070 |
Why?
|
| Anxiety | 2 | 2018 | 156 | 0.070 |
Why?
|
| Self Report | 2 | 2021 | 231 | 0.070 |
Why?
|
| Body Composition | 2 | 2016 | 67 | 0.070 |
Why?
|
| Body Weight | 2 | 2016 | 141 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 1989 | 551 | 0.060 |
Why?
|
| Lipids | 1 | 2005 | 38 | 0.060 |
Why?
|
| Young Adult | 3 | 2018 | 2061 | 0.060 |
Why?
|
| Comorbidity | 1 | 2006 | 508 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 149 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 790 | 0.060 |
Why?
|
| Nurse Practitioners | 2 | 2016 | 106 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2018 | 254 | 0.050 |
Why?
|
| Depression | 2 | 2018 | 481 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2023 | 90 | 0.050 |
Why?
|
| Risk | 1 | 2003 | 223 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2001 | 11 | 0.050 |
Why?
|
| United States Department of Defense | 1 | 2021 | 2 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2021 | 7 | 0.050 |
Why?
|
| Postmenopause | 1 | 2001 | 62 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2014 | 241 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2021 | 19 | 0.050 |
Why?
|
| Triglycerides | 1 | 2001 | 47 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1935 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2001 | 60 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 81 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2020 | 43 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 1999 | 5 | 0.040 |
Why?
|
| Listeriosis | 1 | 1999 | 6 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1999 | 9 | 0.040 |
Why?
|
| Leg | 1 | 1999 | 51 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1997 | 326 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1997 | 301 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 1999 | 184 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 246 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 148 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 258 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2018 | 73 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2019 | 178 | 0.040 |
Why?
|
| Perception | 1 | 2018 | 85 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 85 | 0.040 |
Why?
|
| Telephone | 1 | 2017 | 26 | 0.040 |
Why?
|
| Heart Rate | 2 | 1995 | 160 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 221 | 0.030 |
Why?
|
| Social Class | 1 | 2016 | 69 | 0.030 |
Why?
|
| Georgia | 1 | 2016 | 12 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2016 | 29 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 177 | 0.030 |
Why?
|
| Hemiplegia | 1 | 1995 | 9 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 37 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1994 | 20 | 0.030 |
Why?
|
| Dental Hygienists | 1 | 2014 | 1 | 0.030 |
Why?
|
| Pharmacists | 1 | 2014 | 17 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1994 | 100 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 404 | 0.030 |
Why?
|
| Models, Educational | 1 | 2014 | 37 | 0.030 |
Why?
|
| Education, Medical | 1 | 2014 | 49 | 0.030 |
Why?
|
| Social Networking | 1 | 2013 | 11 | 0.030 |
Why?
|
| Efficiency | 1 | 2013 | 16 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2014 | 94 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 75 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2013 | 89 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1995 | 149 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 409 | 0.030 |
Why?
|
| Propranolol | 1 | 1992 | 10 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2013 | 132 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 264 | 0.030 |
Why?
|
| Rest | 1 | 1992 | 31 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 322 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2012 | 139 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 119 | 0.030 |
Why?
|
| Data Collection | 1 | 2012 | 109 | 0.030 |
Why?
|
| Chronic Disease | 1 | 1994 | 534 | 0.020 |
Why?
|
| Foundations | 1 | 2011 | 3 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1994 | 498 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 116 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1991 | 54 | 0.020 |
Why?
|
| Reperfusion | 1 | 1989 | 7 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 190 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1989 | 95 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 315 | 0.020 |
Why?
|
| Arm | 1 | 2008 | 82 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2007 | 120 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 3665 | 0.020 |
Why?
|
| Rotator Cuff | 1 | 2008 | 283 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 1729 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 4720 | 0.010 |
Why?
|
| Leucine | 1 | 1999 | 15 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1999 | 22 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 195 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 247 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 77 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2001 | 453 | 0.010 |
Why?
|
| Sensation | 1 | 1995 | 17 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1992 | 22 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1992 | 820 | 0.010 |
Why?
|